Agomelatin-Formulierungen, enthaltend Agomelatin in Co-Kristallform

Details

Veröffentlichungs-Nr.

EP2810656

Aktenzeichen

EP13002930

Anmeldetag

6. Juni 2013

Veröffentlichung

2. August 2017

Erteilung

2. August 2017

Rechtsraum

EP

IPC

A61K47/02A61K47/12A61K31/165

Abstract

A pharmaceutical formulation of agomelatine for oral use, comprising - agomelatine in the form of agomelatine co-crystals with organic acids and - pharmaceutically acceptable excipients, in which - the agomelatine co-crystals are used in the form of pre-blend of the agomelatine co-crystals with a glidant, - the ratio of the agomelatine co-crystals to the glidant in the pre-blend is lower than or equal to 30 : 1, and - the free-water content in the used pharmaceutically acceptable excipients is lower than or equal to 7% w/w.

Anmelder

Firmen

Zentiva, k.s.
Zentiva, K.S.

Land

🇨🇿 Tschechien

Fachgebiete